Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases

Drug Discovery Today

Volumn 19, Issue 5, 2014, Pages 654-660

  Dekker, Frank J ^a   Van Den Bosch, Thea ^a   Martin, Nathaniel I ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; HISTONE DEACETYLASE;

ACETYLATION; DRUG SELECTIVITY; INFLAMMATORY DISEASE; REVIEW; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; GENETICS; HUMAN; INFLAMMATION; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; INFLAMMATION; MOLECULAR SEQUENCE DATA;

EID: 84901493375     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.11.012     Document Type: Review

References (68)

1. S.C. Kim et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey Mol. Cell 23 2006 607 618
2. C. Choudhary et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions Science 325 2009 834 840
3. M. Ghizzoni et al. Histone acetyltransferases are crucial regulators in NF-kappaB mediated inflammation Drug Discov. Today 16 2011 504 511
4. M. Kusio-Kobialka et al. Increased acetylation of lysine 317/320 of p53 caused by BCR-ABL protects from cytoplasmic translocation of p53 and mitochondria-dependent apoptosis in response to DNA damage Apoptosis 17 2012 950 963
5. H. Li et al. Regulation of NF-kappaB activity by competition between RelA acetylation and ubiquitination Oncogene 31 2012 611 623
6. L. Chen et al. Duration of nuclear NF-κB action regulated by reversible acetylation Science 293 2001 1653 1657
7. N.D. Perkins Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway Oncogene 25 2006 6717 6730
8. B. Huang et al. Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway Cell Signal. 22 2010 1282 1290
9. R. Kiernan et al. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65 J. Biol. Chem. 278 2003 2758 2766
10. L. Chen et al. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB EMBO J. 21 2002 6539 6548
11. J.S. Lee et al. The language of histone crosstalk Cell 142 2010 682 685
12. X.J. Yang, and E. Seto Lysine acetylation: codified crosstalk with other posttranslational modifications Mol. Cell 31 2008 449 461
13. A. Izzo, and R. Schneider Chatting histone modifications in mammals Brief. Funct. Genomics 9 2010 429 443
14. J.A. Latham, and S.Y. Dent Cross-regulation of histone modifications Nat. Struct. Mol. Biol. 14 2007 1017 1024
15. L.F. Chen et al. NF-kappaB RelA phosphorylation regulates RelA acetylation Mol. Cell. Biol. 25 2005 7966 7975
16. J.Y. Hsu et al. Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes Cell 102 2000 279 291
17. K.M. Johansen, and J. Johansen Regulation of chromatin structure by histone H3S10 phosphorylation Chromosome Res. 14 2006 393 404
18. S.J. Nowak, and V.G. Corces Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation Trends Genet. 20 2004 214 220
19. P. Cheung et al. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation Mol. Cell 5 2000 905 915
20. W.S. Lo et al. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14 Mol. Cell 5 2000 917 926
21. D.G. Edmondson et al. Site-specific loss of acetylation upon phosphorylation of histone H3 J. Biol. Chem. 277 2002 29496 29502
22. H. Wang et al. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase Mol. Cell 8 2001 1207 1217
23. K.P. Nightingale et al. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation J. Biol. Chem. 282 2007 4408 4416
24. C.R. Vakoc et al. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin Mol. Cell 19 2005 381 391
25. K. Nishioka et al. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation Genes Dev. 16 2002 479 489
26. H. Wang et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor Science 293 2001 853 857
27. E. Fabbrizio et al. Negative regulation of transcription by the type II arginine methyltransferase PRMT5 EMBO Rep. 3 2002 641 645
28. S. Pal et al. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad Mol. Cell. Biol. 23 2003 7475 7487
29. Y. Feng et al. Histone H4 acetylation differentially modulates arginine methylation by an in Cis mechanism J. Biol. Chem. 286 2011 20323 20334
30. R. Marmorstein Structure and function of histone acetyltransferases Cell. Mol. Life Sci. 58 2001 693 703
31. C. Buerki et al. Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65 Nucleic Acids Res. 36 2008 1665 1680
32. J.W. Kim et al. New molecular bridge between RelA/p65 and NF-kappaB target genes via histone acetyltransferase TIP60 cofactor J. Biol. Chem. 287 2012 7780 7791
33. F.J. Dekker, and H.J. Haisma Histone acetyl transferases as emerging drug targets Drug Discov. Today 14 2009 942 948
34. K. Balasubramanyam et al. Small molecule modulators of histone acetyltransferase p300 J. Biol. Chem. 278 2003 19134 19140
35. B. Sung et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis Blood 111 2008 4880 4891
36. G. Sbardella et al. Identification of long alkylidenemalonates as novel small molecule modulators of histone acetyltransferases Bioorg. Med. Chem. Lett. 18 2008 2788 2792
37. M. Ghizzoni et al. 6-Alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site Eur. J. Med. Chem. 47 2012 337 344
38. S. Legartova et al. Basic nuclear processes affected by histone acetyltransferases and histone deacetylase inhibitors Epigenomics 5 2013 379 396
39. L. Stimson et al. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity Mol. Cancer Ther. 4 2005 1521 1532
40. F.J. Dekker et al. Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones Bioorg. Med. Chem. 17 2009 460 466
41. M. Ghizzoni et al. Reactivity of isothiazolones and isothiazolone-1- oxides in the inhibition of the PCAF histone acetyltransferase Eur. J. Med. Chem. 44 2009 4855 4861
42. S. Gorsuch et al. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs) Bioorg. Med. Chem. 17 2009 467 474
43. R. Wisastra et al. Isothiazolones; thiol-reactive inhibitors of cysteine protease cathepsin B and histone acetyltransferase PCAF Org. Biomol. Chem. 9 2011 1817 1822
44. E.M. Bowers et al. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor Chem. Biol. 17 2010 471 482
45. F.Q. Zeng et al. Structure-based identification of drug-like inhibitors of p300 histone acetyltransferase Yao Xue Xue Bao 48 2013 700 708
46. F.R. Santer et al. Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines Mol. Cancer Ther. 10 2011 1644 1655
47. X.Y. Zhu et al. p300 exerts an epigenetic role in chronic neuropathic pain through its acetyltransferase activity in rats following chronic constriction injury (CCI) Mol. Pain 8 2012 84
48. I.V. Gregoretti et al. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis J. Mol. Biol. 338 2004 17 31
49. Y.L. Chung et al. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis Mol. Ther. 8 2003 707 717
50. F. Leoni et al. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines Proc. Natl. Acad. Sci. U. S. A. 99 2002 2995 3000
51. A. Villagra et al. Histone deacetylases and the immunological network: implications in cancer and inflammation Oncogene 29 2009 157 173
52. A.M. Grabiec et al. Function of histone deacetylase inhibitors in inflammation Crit. Rev. Immunol. 31 2011 233 263
53. C.A. Dinarello et al. Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer Mol. Med. 17 2011 333 352
54. G. Imre et al. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation Cancer Res. 66 2006 5409 5418
55. H.Y. Lee et al. 1-Arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressors ChemBioChem 14 2013 1248 1254
56. J. Vojinovic et al. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis Arthritis Rheum. 63 2011 1452 1458
57. B.P. Ashburner et al. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression Mol. Cell. Biol. 21 2001 7065 7077
58. Y. Dai et al. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation Mol. Cell. Biol. 25 2005 5429 5444
59. Y.K. Kim et al. Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis Cell Death Differ. 13 2006 2033 2041
60. T. Sato et al. Enhancement of inflammatory protein expression and nuclear factor Kappab (NF-Kappab) activity by trichostatin A (TSA) in OP9 preadipocytes PLoS ONE 8 2013 e59702
61. R.R. Rosato et al. Histone deacetylase inhibitors activate NF-kappaB in human leukemia cells through an ATM/NEMO-related pathway J. Biol. Chem. 285 2010 10064 10077
62. N. Khan et al. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors Biochem. J. 409 2008 581 589
63. M. Lobera et al. Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group Nat. Chem. Biol. 9 2013 319 325
64. E. Ziesche et al. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-kappaB Nucleic Acids Res. 41 2013 90 109
65. C. Sebastian et al. From sirtuin biology to human diseases: an update J. Biol. Chem. 287 2012 42444 42452
66. F. Yeung et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J. 23 2004 2369 2380
67. H. Yang et al. SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-kappaB activity PLoS ONE 7 2012 e46364
68. K.M. Rothgiesser et al. SIRT2 regulates NF-kappaB dependent gene expression through deacetylation of p65 Lys310 J. Cell Sci. 123 2010 4251 4258